Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

16
results for

"Pathology"

Article category

Keywords

Publication year

"Pathology"

Reviews

Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology
Sung Hak Lee, Hyun-Jong Jang
Clin Mol Hepatol 2022;28(4):754-772.
Published online April 21, 2022
DOI: https://doi.org/10.3350/cmh.2021.0394
Molecular tests are necessary to stratify cancer patients for targeted therapy. However, high cost and technical barriers limit the application of these tests, hindering optimal treatment. Recently, deep learning (DL) has been applied to predict molecular test results from digitized images of tissue slides. Furthermore, treatment response and prognosis can be predicted from tissue slides using DL. In this review, we summarized DL-based studies regarding the prediction of genetic mutation, microsatellite instability, tumor mutational burden, molecular subtypes, gene expression, treatment response, and prognosis directly from hematoxylin- and eosin-stained tissue slides. Although performance needs to be improved, these studies clearly demonstrated the feasibility of DL-based prediction of key molecular features in cancer tissues. With the accumulation of data and technical advances, the performance of the DL system could be improved in the near future. Therefore, we expect that DL could provide cost- and time-effective alternative tools for patient stratification in the era of precision oncology.

Citations

Citations to this article as recorded by  Crossref logo
  • Deep learning-driven morphological analysis for assessing EMT state and drug sensitivity of single tumor cell
    Yiyao Yang, Yuxin Guo, Zhaoliang Wang, Yifan Weng, Tingting Hao, Qingqing Zhang, Shuihua Wang, Zhiyong Guo
    Biosensors and Bioelectronics.2026; 291: 118051.     CrossRef
  • Organ cross-talk: molecular mechanisms, biological functions, and therapeutic interventions for diseases
    Huiting Che, Yidan Gao, Yonghu Xu, Hui Xu, Roland Eils, Mei Tian
    Signal Transduction and Targeted Therapy.2026;[Epub]     CrossRef
  • Deep learning-based image analysis in muscle histopathology using photo-realistic synthetic data
    Leonid Mill, Oliver Aust, Jochen A. Ackermann, Philipp Burger, Monica Pascual, Katrin Palumbo-Zerr, Gerhard Krönke, Stefan Uderhardt, Georg Schett, Christoph S. Clemen, Christian Holtzhausen, Samir Jabari, Rolf Schröder, Andreas Maier, Anika Grüneboom
    Communications Medicine.2025;[Epub]     CrossRef
  • Deep Learning–Powered Whole Slide Image Analysis in Cancer Pathology
    Chengrun Dang, Zhuang Qi, Tao Xu, Mingkai Gu, Jiajia Chen, Jie Wu, Yuxin Lin, Xin Qi
    Laboratory Investigation.2025; 105(7): 104186.     CrossRef
  • Recent advances and challenges in colorectal cancer: From molecular research to treatment
    Gao-Xiu Qi, Rui-Xia Zhao, Chen Gao, Zeng-Yan Ma, Shang Wang, Jing Xu
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Deep Learning Model-Based Architectures for Lung Tumor Mutation Profiling: A Systematic Review
    Samanta Ortuño-Miquel, Reyes Roca, Cristina Alenda, Francisco Aranda, Natividad Martínez-Banaclocha, Sandra Amador, David Gil
    Cancers.2025; 17(22): 3619.     CrossRef
  • AI-Driven Digital Pathology: Deep Learning and Multimodal Integration for Precision Oncology
    Hyun-Jong Jang, Sung Hak Lee
    International Journal of Molecular Sciences.2025; 27(1): 379.     CrossRef
  • Training immunophenotyping deep learning models with the same-section ground truth cell label derivation method improves virtual staining accuracy
    Abu Bakr Azam, Felicia Wee, Juha P. Väyrynen, Willa Wen-You Yim, Yue Zhen Xue, Bok Leong Chua, Jeffrey Chun Tatt Lim, Aditya Chidambaram Somasundaram, Daniel Shao Weng Tan, Angela Takano, Chun Yuen Chow, Li Yan Khor, Tony Kiat Hon Lim, Joe Yeong, Mai Chan
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”
    Su Bin Lim, Hyo Jung Cho
    Clinical and Molecular Hepatology.2024; 30(4): 1009.     CrossRef
  • Integrating transcriptomic data and digital pathology for NRG-based prediction of prognosis and therapy response in gastric cancer
    Qiuyan Sun, Tan Li, Zheng Wei, Zhiyi Ye, Xu Zhao, Jingjing Jing
    Annals of Medicine.2024;[Epub]     CrossRef
  • Development and validation of a prognostic nomogram including inflammatory indicators for overall survival in hepatocellular carcinoma patients treated primarily with surgery or loco-regional therapy: A single-center retrospective study
    Xin Wang, Jing Xu, Zhenya Jia, Guoping Sun
    Medicine.2024; 103(50): e40889.     CrossRef
  • Deep learning captures selective features for discrimination of microsatellite instability from pathologic tissue slides of gastric cancer
    Sung Hak Lee, Yujin Lee, Hyun‐Jong Jang
    International Journal of Cancer.2023; 152(2): 298.     CrossRef
  • A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma
    Chih-Lang Lin, Kung-Hao Liang, Ching-Chih Hu, Cheng-Hung Chien, Li-Wei Chen, Rong-Nan Chien, Yang-Hsiang Lin, Chau-Ting Yeh
    International Journal of Molecular Sciences.2023; 24(2): 1681.     CrossRef
  • Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues
    Violetta Rosiek, Ksenia Janas, Beata Kos-Kudła
    Biomedicines.2023; 11(3): 842.     CrossRef
  • Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC
    Wang Yao, Ran Wei, Jia Jia, Wang Li, Mengxuan Zuo, Shuqing Zhuo, Ge Shi, Peihong Wu, Chao An
    Therapeutic Advances in Medical Oncology.2023;[Epub]     CrossRef
  • High-content microscopy reveals a morphological signature of bortezomib resistance
    Megan E Kelley, Adi Y Berman, David R Stirling, Beth A Cimini, Yu Han, Shantanu Singh, Anne E Carpenter, Tarun M Kapoor, Gregory P Way
    eLife.2023;[Epub]     CrossRef
  • Deep Learning-Based Classification of Uterine Cervical and Endometrial Cancer Subtypes from Whole-Slide Histopathology Images
    JaeYen Song, Soyoung Im, Sung Hak Lee, Hyun-Jong Jang
    Diagnostics.2022; 12(11): 2623.     CrossRef
  • Deep Learning-Based Prediction of Molecular Tumor Biomarkers from H&E: A Practical Review
    Heather D. Couture
    Journal of Personalized Medicine.2022; 12(12): 2022.     CrossRef
  • 10,081 View
  • 269 Download
  • 19 Web of Science
  • Crossref
The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology
Youngseok Lee, Jong-Hoon Kim
Clin Mol Hepatol 2022;28(4):706-724.
Published online March 2, 2022
DOI: https://doi.org/10.3350/cmh.2021.0390
Extracellular vesicles (EVs) are membrane-enclosed particles released from almost all cell types. EVs mediate intercellular communication by delivering their surface and luminal cargoes, including nucleic acids, proteins, and lipids, which reflect the pathophysiological conditions of their cellular origins. Hepatocytes and hepatic non-parenchymal cells utilize EVs to regulate a wide spectrum of biological events inside the liver and transfer them to distant organs through systemic circulation. The liver also receives EVs from multiple organs and integrates these extrahepatic signals that participate in pathophysiological processes. EVs have recently attracted growing attention for their crucial roles in maintaining and regulating hepatic homeostasis. This review summarizes the roles of EVs in intrahepatic and interorgan communications under different pathophysiological conditions of the liver, with a focus on chronic liver diseases including nonalcoholic steatohepatitis, alcoholic hepatitis, viral hepatitis, liver fibrosis, and hepatocellular carcinoma. This review also discusses recent progress for potential therapeutic applications of EVs by targeting or enhancing EV-mediated cellular communication for the treatment of liver diseases.

Citations

Citations to this article as recorded by  Crossref logo
  • Rational design of extracellular vesicles for targeted drug delivery across physiological barriers
    Helna M. Baby, Hengli Zhang, Andrew Selvadoss, Tanvi V. Pathrikar, Ambika G. Bajpayee
    Nano Today.2026; 66: 102920.     CrossRef
  • Therapeutic drug monitoring, liquid biopsies or pharmacogenomics for prediction of human drug metabolism and response
    Magnus Ingelman‐Sundberg, Espen Molden
    British Journal of Clinical Pharmacology.2025; 91(6): 1569.     CrossRef
  • hESC-derived extracellular vesicles enriched with MFGE-8 and the GSH redox system act as senotherapeutics for neural stem cells in ischemic stroke
    Youngseok Lee, Jihun Lee, Jeongjun Kim, Seunghyun Cho, Hye-Jin Lee, Dongho Geum, Dong-Hyuk Park, Jong-Hoon Kim
    Free Radical Biology and Medicine.2025; 229: 333.     CrossRef
  • Optimizing therapeutic outcomes: preconditioning strategies for MSC-derived extracellular vesicles
    Yuqi Song, Fengrui Liang, Weikun Tian, Erin Rayhill, Liping Ye, Xinghan Tian
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Extracellular vesicle-mediated bidirectional communication between the liver and other organs: mechanistic exploration and prospects for clinical applications
    Wenhui Mo, Yunke Peng, Yanyi Zheng, Shenglan Zhao, Liling Deng, Xiaoli Fan
    Journal of Nanobiotechnology.2025;[Epub]     CrossRef
  • MFGE‐8, a Corona Protein on Extracellular Vesicles, Mediates Self‐Renewal and Survival of Human Pluripotent Stem Cells
    Youngseok Lee, Hyojin Kim, Heeseok Yoon, Seunghyun Cho, Jeongjun Kim, Jihun Lee, Sang‐Hun Choi, Hyesun Cho, Dong‐Hun Woo, Jung‐Hyuck Park, Choongseong Han, Jong‐Hoon Kim
    Journal of Extracellular Vesicles.2025;[Epub]     CrossRef
  • Machine Learning Approach and Bioinformatics Analysis Discovered Key Genomic Signatures for Hepatitis B Virus-Associated Hepatocyte Remodeling and Hepatocellular Carcinoma
    Adane Adugna, Gashaw Azanaw Amare, Mohammed Jemal
    Cancer Informatics.2025;[Epub]     CrossRef
  • The Role of Extracellular Vesicles in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Liver Diseases
    Elena Grossini, Mohammad Mostafa Ola Pour, Sakthipriyan Venkatesan
    International Journal of Molecular Sciences.2025; 26(11): 5033.     CrossRef
  • Extracellular Vesicles for Clinical Diagnostics: From Bulk Measurements to Single-Vesicle Analysis
    Hai Linh Tran, Wenshu Zheng, David A. Issadore, Hyungsoon Im, Yoon-Kyoung Cho, Yuanqing Zhang, Dingbin Liu, Yang Liu, Bo Li, Fei Liu, David Tai Wai Wong, Jiashu Sun, Kun Qian, Mei He, Meihua Wan, Yong Zeng, Ke Cheng, Tony Jun Huang, Daniel T. Chiu, Luke P
    ACS Nano.2025; 19(31): 28021.     CrossRef
  • Extracellular Vesicles as Biomarkers in Chronic Hepatobiliary Diseases: An Overview of Their Interplay
    Eleni Myrto Trifylli, Sotirios P. Fortis, Anastasios G. Kriebardis, Nikolaos Papadopoulos, Evangelos Koustas, Panagiotis Sarantis, Spilios Manolakopoulos, Melanie Deutsch
    International Journal of Molecular Sciences.2025; 26(13): 6333.     CrossRef
  • The Molecular Dynamics of Extracellular Vesicles and their Protein Corona in the Secretomes of Stem Cells
    Youngseok Lee, Seunghyun Cho, Heeseok Yoon, Jeongjun Kim, Jong-Hoon Kim
    Stem Cell Reviews and Reports.2025; 21(8): 2426.     CrossRef
  • Human Umbilical Cord Blood Plasma‐Derived Exosomal miR‐410‐3p Alleviates Liver Injury by Regulating the Mitochondria‐Mediated Antiapoptotic Signaling
    Lin Zhang, Yushuang Ren, Dongsheng Su, Qingyuan Jiang, Huan Peng, Fuyi Cheng, Hantao Zhang, Xue Bai, Xiao Wei, Weixiao Yang, Pusong Zhao, Yixin Ye, Gang Shi, Hongxin Deng
    MedComm.2025;[Epub]     CrossRef
  • Exosomes in Metabolic Diseases: From Molecular Mechanisms to Clinical Applications
    Yanting Wu, Shanshan Yang, You Zhang, Zhiguang Su
    MedComm – Future Medicine.2025;[Epub]     CrossRef
  • Tumour-Derived Extracellular Vesicles in Chemotherapy Resistance: Molecular Pathways, Clinical Implications and Therapeutic Opportunities
    Rupali J. Ghule, Priyal N. Jadhav, Yogeshwari N. Sanap, Mukund M. Pache, Avinash B. Darekar
    Asian Journal of Research in Pharmaceutical Sciences.2025; : 371.     CrossRef
  • Extracellular Vesicle-Derived microRNAs: Novel Non-Invasive Biomarkers for Gastrointestinal Malignancies
    Daniela Nardozi, Valeria Lucarini, Valentina Angiolini, Nicole Feverati, Monica Benvenuto, Chiara Focaccetti, Letizia Del Conte, Olga Buccitti, Camilla Palumbo, Loredana Cifaldi, Elisabetta Ferretti, Roberto Bei, Laura Masuelli
    International Journal of Molecular Sciences.2025; 27(1): 10.     CrossRef
  • Targeted blockade of extracellular vesicles-mediated profibrotic vicious circle using EVs-based dual-drug delivery system to prevent liver fibrosis
    Jie Sun, Yi Shen, Xiaoze Wang, Ruoting Men, Xian Xing, Linling Lv, Fan Yang, Mengyi Shen, Yanyi Zheng, Xiaoli Fan, Jingping Liu, Li Yang
    Journal of Nanobiotechnology.2025;[Epub]     CrossRef
  • Metabolic and circadian inputs encode anticipatory biogenesis of hepatic fed microRNAs
    Sandra Usha Satheesan, Shreyam Chowdhury, Ullas Kolthur-Seetharam
    Life Science Alliance.2024; 7(5): e202302180.     CrossRef
  • A century journey of organelles research in the plant endomembrane system
    Xiaohong Zhuang, Ruixi Li, Liwen Jiang
    The Plant Cell.2024; 36(5): 1312.     CrossRef
  • Therapeutic potential of RNA-enriched extracellular vesicles: The next generation in RNA delivery via biogenic nanoparticles
    Muskan Muskan, Pevindu Abeysinghe, Riccardo Cecchin, Heather Branscome, Kevin V. Morris, Fatah Kashanchi
    Molecular Therapy.2024; 32(9): 2939.     CrossRef
  • Extracellular vesicles: Function, resilience, biomarker, bioengineering, and clinical implications
    Der-Shan Sun, Hsin-Hou Chang
    Tzu Chi Medical Journal.2024;[Epub]     CrossRef
  • Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy
    Adane Adugna, Yalew Muche, Abateneh Melkamu, Mohammed Jemal, Habtamu Belew, Gashaw Azanaw Amare
    Heliyon.2024; 10(14): e34288.     CrossRef
  • Novel insights into the role of immunomodulatory extracellular vesicles in the pathogenesis of liver fibrosis
    Jiaxuan Li, Yue Yuan, Qinggang Fu, Min Chen, Huifang Liang, Xiaoping Chen, Xin Long, Bixiang Zhang, Jianping Zhao, Qian Chen
    Biomarker Research.2024;[Epub]     CrossRef
  • The role of macrophages in liver fibrosis: composition, heterogeneity, and therapeutic strategies
    Xiaocao Ma, Jia Qiu, Shubiao Zou, Liling Tan, Tingting Miao
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
    Hui Gao, Yanchao Jiang, Ge Zeng, Nazmul Huda, Themis Thoudam, Zhihong Yang, Suthat Liangpunsakul, Jing Ma
    eGastroenterology.2024; 2(4): e100104.     CrossRef
  • Characterization of large extracellular vesicles (L-EV) derived from human regulatory macrophages (Mreg): novel mediators in wound healing and angiogenesis?
    Martin Albrecht, Lars Hummitzsch, Rene Rusch, Katharina Heß, Markus Steinfath, Jochen Cremer, Frank Lichte, Fred Fändrich, Rouven Berndt, Karina Zitta
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • Exosomes: Nomenclature, Isolation, and Biological Roles in Liver Diseases
    Seol Hee Park, Eun Kyeong Lee, Joowon Yim, Min Hoo Lee, Eojin Lee, Young-Sun Lee, Wonhyo Seo
    Biomolecules & Therapeutics.2023; 31(3): 253.     CrossRef
  • Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells
    Elena Grossini, Carlo Smirne, Sakthipriyan Venkatesan, Stelvio Tonello, Davide D’Onghia, Rosalba Minisini, Vincenzo Cantaluppi, Pier Paolo Sainaghi, Cristoforo Comi, Adele Tanzi, Benedetta Bussolati, Mario Pirisi
    International Journal of Molecular Sciences.2023; 24(12): 10197.     CrossRef
  • Therapeutic Strategy of Mesenchymal-Stem-Cell-Derived Extracellular Vesicles as Regenerative Medicine
    Yasunari Matsuzaka, Ryu Yashiro
    International Journal of Molecular Sciences.2022; 23(12): 6480.     CrossRef
  • Current management of liver diseases and the role of multidisciplinary approach
    Nouhoum Bouare
    World Journal of Hepatology.2022; 14(11): 1920.     CrossRef
  • Regulation of Extracellular Vesicle-Mediated Immune Responses against Antigen-Specific Presentation
    Yasunari Matsuzaka, Ryu Yashiro
    Vaccines.2022; 10(10): 1691.     CrossRef
  • 17,863 View
  • 305 Download
  • 27 Web of Science
  • Crossref
Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
Mina Komuta
Clin Mol Hepatol 2022;28(3):396-407.
Published online January 14, 2022
DOI: https://doi.org/10.3350/cmh.2021.0287
Treatment of intrahepatic cholangiocarcinoma (iCCA) is currently at a significant turning point due to the identification of isocitrate dehydrogenase (IDH) mutations and fibroblast growth factor receptor (FGFR) fusions that can be targeted with currently available therapies. Clinical trials of these targeted therapies have been promising, and the iCCA patients who may benefit from these targeted treatments can be identified by pathological examination prior to molecular investigations. This is because IDH mutations and FGFR fusions are mainly seen in the small duct type iCCA, a subtype of iCCA defined by the 5th World Health Organization classification, which can be recognized by the pathological diagnostic process. Therefore, pathology plays an important role in precision medicine for iCCA, not only in confirming the diagnosis, but also in identifying the iCCA patients who may benefit from targeted treatments. However, caution is advised with the pathological diagnosis, as iCCA shows tumour heterogeneity, making it difficult to distinguish small duct type iCCA from hepatocellular carcinoma (HCC), and combined HCC-CCA. This review focuses on the pathological/molecular features of both subtypes of iCCA (large and small duct types), as well as their diagnostic pitfalls, clinical relevance, and future perspectives.

Citations

Citations to this article as recorded by  Crossref logo
  • Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review
    Masayuki Akita, Hiroaki Yanagimoto, Daisuke Tsugawa, Yoh Zen, Takumi Fukumoto
    Surgery Today.2025; 55(1): 1.     CrossRef
  • Standardizing the reporting of cholangiocarcinoma: the society of abdominal radiology disease focused panel on cholangiocarinoma lexicon
    Robert M. Marks, Hina Arif, Maria Antonietta Bali, Ryan L. Brunsing, Guilherme M. Cunha, Hala Khasawneh, Maria El Homsi, Charanjeet Singh, Raj Paspulati, Andrea Kierans, Aliya Qayyum
    Abdominal Radiology.2025; 50(7): 2858.     CrossRef
  • SQSTM1/p62 confers resistance of intrahepatic cholangiocarcinoma cells to 5-Fluorouracil by promoting Nrf2 nuclear translocation
    Xuanming Luo, Qinwen Tai, Xuan Liu, Xingni Zhou, Wenxiang Li, Houbao Liu, Zhenbin Ding, Miyesaier Abudureyimu
    Molecular & Cellular Toxicology.2025; 21(4): 917.     CrossRef
  • Correspondence to editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”
    Yu-Hang Ye, Shao-Lai Zhou
    Clinical and Molecular Hepatology.2025; 31(1): e90.     CrossRef
  • Conversion treatment for advanced intrahepatic cholangiocarcinoma: Opportunities and challenges
    Jun-Jie Liu, Mi Zhou, Tong Yuan, Zhi-Yong Huang, Zun-Yi Zhang
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Contrast-enhanced ultrasound imaging characteristics of intrahepatic cholangiocarcinoma with actionable gene variants detected by comprehensive cancer gene panel testing
    Kazunori Nakaoka, Eizaburo Ohno, Seiji Yamada, Teiji Kuzuya, Tamotsu Sudo, Sayaka Ueno, Hiroyuki Tanaka, Yutaka Sasaki, Ryoji Miyahara, Senju Hashimoto, Yoshiki Hirooka
    International Journal of Clinical Oncology.2025; 30(7): 1398.     CrossRef
  • Diagnosis and Treatment of Intrahepatic Cholangiocarcinoma
    Takamichi Ishii, Etsuro Hatano
    Kanzo.2025; 66(6): 213.     CrossRef
  • Comparison of MRI and prognostic features of intrahepatic cholangiocarcinoma between patients with and without hepatitis B virus infection
    Se Jin Choi, Dong Hwan Kim, Sang Hyun Choi, So Yeon Kim, Seung Soo Lee, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin
    Abdominal Radiology.2025; 50(12): 5820.     CrossRef
  • Association between ultrasound-based biliary and parenchymal intrahepatic mass-forming cholangiocarcinoma subtypes and clinicopathological features and survival
    Cong-Jian Wen, Hui Liu, Li-Ping Sun, Chong-Ke Zhao, Hao-Hao Yin, Li-Fan Wang, Ming-Rui Zhu, Yi-Kang Sun, Ya-Qin Zhang, Zi-Tong Chen, Xi Wang, Han-Sheng Xia, Hong Han, Hui-Xiong Xu, Bo-Yang Zhou
    Insights into Imaging.2025;[Epub]     CrossRef
  • FXYD3 Promotes Tumor Progression by Binding With IRF7 to Regulate JAK2/STAT5 Signaling in Intrahepatic Cholangiocarcinoma
    Yan Zhou, Xiaofeng Shen, Shuo Zhang, XiaoHong Pu, Zipeng Xu, Xiang Zhao, Wei Feng, Yuan Liang, Xingtao He, Aihua Yang, Yudong Qiu, Yihang Yuan, Chaobo Chen, Jun Chen
    Advanced Science.2025;[Epub]     CrossRef
  • Liver transplantation for intrahepatic cholangiocarcinoma: Insights from a National Registry Study in China
    Pengcheng Wei, Delin Ma, Chen Lo, Yongjing Luo, Jie Gao, Lei Huang, Jiye Zhu, Guangming Li, Shusen Zheng, Zhao Li
    Medicine.2025; 104(42): e44942.     CrossRef
  • Exploratory study on the role of Clonorchis sinensis infection in promoting cholangiocarcinoma progression
    Shitao Li, Yiqi Jiang, Jun Kawanokuchi, Xueling Deng, Yuhong Wu, Yu Chen, Lixia Zeng, Ganghuan Deng, Damian Li, Tingzheng Zhan, Dengyu Liu, Ning Ma, Zeli Tang
    Parasites & Vectors.2025;[Epub]     CrossRef
  • Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
    Liangtao Ye, Julia S. Schneider, Najib Ben Khaled, Peter Schirmacher, Carolin Seifert, Lea Frey, Yulong He, Andreas Geier, Enrico N. De Toni, Changhua Zhang, Florian P. Reiter
    Liver Cancer.2024; 13(1): 6.     CrossRef
  • UBA3 promotes the occurrence and metastasis of intrahepatic cholangiocarcinoma through MAPK signaling pathway
    Huhu Zhang, Jiahua Yang, Qinghang Song, Xiaoyan Ding, Fulin Sun, Lina Yang
    Acta Biochimica et Biophysica Sinica.2024; 56(2): 199.     CrossRef
  • Intrahepatic cholangiocarcinoma: histological diversity and the role of the pathologist
    Mina Komuta
    Journal of Liver Cancer.2024; 24(1): 17.     CrossRef
  • Targeted therapies in advanced biliary malignancies: a clinical review
    Udhayvir S. Grewal, Shiva J. Gaddam, Muhammad S. Beg, Timothy J. Brown
    Expert Review of Anticancer Therapy.2024; 24(9): 869.     CrossRef
  • Identification of molecular subtypes based on bile acid metabolism in cholangiocarcinoma
    Mingxia Deng, Jing Liu, Li Zhang, Yan Lou, Yunqing Qiu
    BMC Cancer.2024;[Epub]     CrossRef
  • Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
    Hee Seung Lee, Dai Hoon Han, Kyungjoo Cho, Soo Been Park, Chanyang Kim, Galam Leem, Dawoon E. Jung, Soon Sung Kwon, Chul Hoon Kim, Jung Hyun Jo, Hye Won Lee, Si Young Song, Jun Yong Park
    Nature Communications.2023;[Epub]     CrossRef
  • Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line, ICC-X3
    Hao Xu, Wei Luo, Zhenjie Zhao, Xin Miao, Changpeng Chai, Jinjing Hu, Huan Tang, Hui Zhang, Wence Zhou
    Human Cell.2023; 36(2): 854.     CrossRef
  • A Case of Prostatic Metastasis from Intrahepatic Cholangiocarcinoma: An Extremely Rare Event
    Sanathan Aiyadurai, Tulika Garg, Tass Sayeed, Zainab Shahbaz, Idowu O Adewole, Enoh Nguty Nkeng, Abia Joseph, Datiobong Udoeyop, Yusra Qamar, Aadil Khan
    Cureus.2023;[Epub]     CrossRef
  • Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma
    Naoshi Nishida, Tomoko Aoki, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima, Masatoshi Kudo
    Cancers.2023; 15(8): 2379.     CrossRef
  • Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
    Xianzhe Yu, Lingling Zhu, Ting Wang, Jiang Chen
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features
    Yi Chen, Xiaoling Liu, Liyun Huang, Lihong Chen, Bin Wang
    Expert Review of Molecular Diagnostics.2023; 23(5): 445.     CrossRef
  • MCM6 promotes intrahepatic cholangiocarcinoma progression by upregulating E2F1 and enhancing epithelial–mesenchymal transition
    Chongqing Gao, Jing Li, Fuling Zeng, Lijuan Wang, Kaiyun Chen, Dong Chen, Jian Hong, Chen Qu
    Carcinogenesis.2023; 44(4): 279.     CrossRef
  • Novel cell subtypes of SPP1 + S100P+, MS4A1-SPP1 + S100P+ were key subpopulations in intrahepatic cholangiocarcinoma
    Zixue Xuan, Linqing Liu, Guobing Zhang, Xiaowei Zheng, Jinying Jiang, Kai Wang, Ping Huang
    Biochimica et Biophysica Acta (BBA) - General Subjects.2023; 1867(9): 130420.     CrossRef
  • Liver Transplantation for Incidental Cholangiocarcinoma or Combined Hepatocellular Carcinoma/Cholangiocarcinoma—Own Experiences and Review of the Literature
    Laura Schwenk, Oliver Rohland, Aladdin Ali-Deeb, Felix Dondorf, Utz Settmacher, Falk Rauchfuß
    Cancers.2023; 15(14): 3609.     CrossRef
  • Beyond the Lab and Into the Hospital: An Outlook on the Clinical Utility of Spatial Omics Technologies
    Dean M. Pucciarelli, Benjamin Y. Lu, Inti Zlobec, Marcello DiStasio
    GEN Biotechnology.2023; 2(5): 360.     CrossRef
  • Targeted mutation-based therapy for intrahepatic cholangiocarcinoma
    Facai Yang, Yinghe Qiu, Bin Yi
    Hepatoma Research.2023;[Epub]     CrossRef
  • Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
    Rocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, Matias A Avila, Maria Guido, Cedric Coulouarn, Chiara Braconi, Adam E Frampton, John Bridgewater, Diletta Overi, Stephen P Pereira, Marco Rengo, Jakob N Kather, Angela Lamarca, Federica Pedica, Alej
    Gut.2022; 71(8): 1669.     CrossRef
  • 11,784 View
  • 402 Download
  • 29 Web of Science
  • Crossref

Hepatic neoplasm

Pathologic differential diagnosis of metastatic carcinoma in the liver
Jeong Hwan Park, Jung Ho Kim
Clin Mol Hepatol 2019;25(1):12-20.
Published online October 5, 2018
DOI: https://doi.org/10.3350/cmh.2018.0067
The liver is one of the most common sites to which malignancies preferentially metastasize. Although a substantial number of liver malignancies are primary tumors, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma, the metastasis of carcinomas to the liver is relatively common and frequently encountered in clinical settings. Representative carcinomas that frequently metastasize to the liver include colorectal carcinoma, breast carcinoma, neuroendocrine tumors, lung carcinoma, and gastric carcinoma. The diagnostic confirmation of suspected metastatic lesions in the liver is generally achieved through a histopathologic examination of biopsy tissues. Although morphology is the most important feature for a pathologic differential diagnosis of metastatic carcinomas, immunohistochemical studies facilitate the differentiation of metastatic carcinoma origins and subtypes. Useful immunohistochemical markers for the differential diagnosis of metastatic carcinomas in the liver include cytokeratins (CK7, CK19, and CK20), neuroendocrine markers (CD56, synaptophysin, and chromogranin A), and tissue-specific markers (CDX2, SATB2, TTF-1, GCDFP-15, mammaglobin, etc.). Here, we provide a brief review about the pathologic differential diagnosis of major metastatic carcinomas in the liver.

Citations

Citations to this article as recorded by  Crossref logo
  • Endoscopic ultrasound‐guided tissue acquisition for focal liver lesions in patients with a history of multiple primary malignant neoplasms
    Yuichi Takano, Naoki Tamai, Masataka Yamawaki, Jun Noda, Tetsushi Azami, Fumitaka Niiya, Fumiya Nishimoto, Naotaka Maruoka, Tatsuya Yamagami, Masatsugu Nagahama
    DEN Open.2025;[Epub]     CrossRef
  • Machine learning-assisted pattern recognition and imaging of multiplexed cancer cells via a porphyrin-embedded dendrimer array
    Jiabao Hu, Weiwei Ni, Mengting Han, Yunzhen Zhan, Fei Li, Hui Huang, Jinsong Han
    Journal of Materials Chemistry B.2025; 13(1): 207.     CrossRef
  • Molecular subtypes of intrahepatic cholangiocarcinoma
    Alessandro De Santis, Lei Zhu, Jianxin Tao, Christoph Reißfelder, Sebastian Schölch
    Trends in Molecular Medicine.2025; 31(8): 755.     CrossRef
  • Biliary Adenofibroma and the Threat of Malignant Transformation
    Mohamed A. Youssef, Joseph Gosnell, Heather L. Stevenson
    International Journal of Surgical Pathology.2025; 33(7): 1658.     CrossRef
  • Long-term SiNPs exposure induced genetic instability and malignant transformation via SQSTM1/p62-mediated autophagy dysfunction in lungs
    Kanglin Yan, Yuexiao Ma, Xuemin Shi, Chen Liang, Ruiyang Ding, Zhiwei Sun, Junchao Duan
    Materials Today Bio.2025; 33: 101972.     CrossRef
  • Metastatic hepatic carcinoma: Mechanisms, emerging therapeutics, and future perspectives
    Jianfeng Zhou, Yuan Sui, Zhihua Chen
    iScience.2025; 28(7): 112902.     CrossRef
  • Quantitative Assessment of Peritumoral Stiffness Using Shell Elastography Enhances the Differentiation of Hepatocellular Carcinoma From Metastatic Liver Carcinoma
    Yang Li, Zhaoyu Wu, Min Zhu, Banban Wu, Yibin Wang
    Journal of Ultrasound in Medicine.2025;[Epub]     CrossRef
  • Discovery of novel DNA methylation biomarker panels for the diagnosis and differentiation between common adenocarcinomas and their liver metastases
    Tina Draškovič, Nina Hauptman
    Scientific Reports.2024;[Epub]     CrossRef
  • Identifying primary tumor site of origin for liver metastases via a combination of handcrafted and deep learning features
    Chuheng Chen, Cheng Lu, Vidya Viswanathan, Brandon Maveal, Bhunesh Maheshwari, Joseph Willis, Anant Madabhushi
    The Journal of Pathology: Clinical Research.2024;[Epub]     CrossRef
  • Advancing Differentiation of Hepatic Metastases in Malignant Melanoma through Dual-Energy Computed Tomography Rho/Z Maps
    Ibrahim Yel, Vitali Koch, Leon D. Gruenewald, Scherwin Mahmoudi, Leona S. Alizadeh, Aynur Goekduman, Katrin Eichler, Thomas J. Vogl, Mirela Dimitrova, Christian Booz
    Diagnostics.2024; 14(7): 742.     CrossRef
  • Exploring the potential of drug repurposing for liver diseases: A comprehensive study
    Fares E.M. Ali, Mustafa Ahmed Abdel-Reheim, Emad H.M. Hassanein, Mostafa K. Abd El-Aziz, Hanan S. Althagafy, Khalid S.A. Badran
    Life Sciences.2024; 347: 122642.     CrossRef
  • Impact of immunotherapy on liver metastasis
    Zhuo Fu, Ming-Wei Wang, Ya-Hui Liu, Yan Jiao
    World Journal of Gastrointestinal Surgery.2024; 16(7): 1969.     CrossRef
  • An audit of metastatic tumors to the liver highlighting the spectrum of differential diagnosis: A retrospective study from a tertiary cancer center in North India
    Neha Singh, Ipsita Dhal, Kirti Rajput, Zachariah Chowdhury, Shashikant Patne, Parul Tripathi, Swapnil Patel, Mayank Tripathi, Durgatosh Pandey, Bipinesh Sansar
    Cancer Research, Statistics, and Treatment.2024; 7(2): 149.     CrossRef
  • Automated diagnosis and classification of liver cancers using deep learning techniques: a systematic review
    Sarthak Grover, Surbhi Gupta
    Discover Applied Sciences.2024;[Epub]     CrossRef
  • Benefits and drawbacks of radiofrequency ablation via percutaneous or minimally invasive surgery for treating hepatocellular carcinoma
    Ching-Lung Hsieh, Cheng-Ming Peng, Chun-Wen Chen, Chang-Hsien Liu, Chih-Tao Teng, Yi-Jui Liu
    World Journal of Gastrointestinal Surgery.2024; 16(11): 3400.     CrossRef
  • Albumin, filamin-A and cytokeratin 19 help distinguish intrahepatic cholangiocarcinoma from extrahepatic adenocarcinoma
    Yeon Seung Chung, Youngsic Jeon, Jeong Eun Yoo, Taek Chung, Hyang Joo Ryu, Hyunki Kim, Hyungjin Rhee, Young Nyun Park
    Hepatology International.2023; 17(1): 77.     CrossRef
  • Una causa inusual de fallo hepático fulminante: infiltración metastásica por carcinoma ductal infiltrante de mama
    Francisco Javier Pardilla Moraleda, Rosario Serrano Pardo, Lourdes del Campo del Val, Luisa García-Buey
    Gastroenterología y Hepatología.2023; 46(9): 710.     CrossRef
  • Laparoscopic Hepatectomy for Hepatocellular Carcinoma
    Qiyu Qiu
    Highlights in Science, Engineering and Technology.2023; 30: 12.     CrossRef
  • EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
    Domenico Alvaro, Gregory J. Gores, Joël Walicki, Cesare Hassan, Gonzalo Sapisochin, Mina Komuta, Alejandro Forner, Juan W. Valle, Andrea Laghi, Sumera I. Ilyas, Joong-Won Park, Robin K. Kelley, Maria Reig, Bruno Sangro
    Journal of Hepatology.2023; 79(1): 181.     CrossRef
  • Breast mass as the first sign of metastasis from rectal carcinoma: a case report and review of the literature
    Jiawei Xu, Chao Liu, Chengdong Yu, Tenghua Yu, Fan Fan, Xiaofang Zhang, Chuansheng Huang, Wen Chen, Zhengkui Sun, Meng Zhou
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Carcinoma of unknown primary (CUP): an update for histopathologists
    Katie Beauchamp, Bruce Moran, Timothy O’Brien, Donal Brennan, John Crown, Kieran Sheahan, Maura Bríd Cotter
    Cancer and Metastasis Reviews.2023; 42(4): 1189.     CrossRef
  • Implementation of deep learning in liver pathology optimizes diagnosis of benign lesions and adenocarcinoma metastasis
    Mark Kriegsmann, Katharina Kriegsmann, Georg Steinbuss, Christiane Zgorzelski, Thomas Albrecht, Stefan Heinrich, Stefan Farkas, Wilfried Roth, Hien Dang, Anne Hausen, Matthias M. Gaida
    Clinical and Translational Medicine.2023;[Epub]     CrossRef
  • An unusual cause of fulminant hepatic failure: Metastatic infiltration by infiltrating ductal carcinoma of the breast
    Francisco Javier Pardilla Moraleda, Rosario Serrano Pardo, Lourdes del Campo del Val, Luisa García-Buey
    Gastroenterología y Hepatología (English Edition).2023; 46(9): 710.     CrossRef
  • Deep Learning for the Pathologic Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colorectal Cancer
    Hyun-Jong Jang, Jai-Hyang Go, Younghoon Kim, Sung Hak Lee
    Cancers.2023; 15(22): 5389.     CrossRef
  • Primäre und sekundäre Lebertumore
    Nabeel Mansour, Max Seidensticker, Maurice M. Heimer
    Angewandte Nuklearmedizin.2023; 46(04): 323.     CrossRef
  • Liver metastasis of breast carcinoma: An unusual presentation and growth pattern
    Mine Özşen, Nesrin Uğraş, Ömer Yerci, Adem Deligönül
    Indian Journal of Pathology and Microbiology.2023; 66(4): 877.     CrossRef
  • Metastatic Liver Tumors in Surgical Pathology: Impact of Contemporary Diagnostic and Therapeutic Paradigms in a Tertiary Care Center
    Ayşe Armutlu, Omer Saeed, Romil Saxena
    International Journal of Surgical Pathology.2022; 30(2): 138.     CrossRef
  • Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma
    Taek Chung, Young Nyun Park
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand
    Supinda Koonmee, Sakkarn Sangkhamanon, Piyapharom Intarawichian, Chaiwat Aphivatanasiri, Waritta Kunprom, Prakasit Sa-ngiamwibool, Suwit Balthaisong, Chitsakul Phuyao, Piya Prajumwongs, Reza Alaghehbandan, Malinee Thanee
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review
    Romans Uljanovs, Stanislavs Sinkarevs, Boriss Strumfs, Liga Vidusa, Kristine Merkurjeva, Ilze Strumfa
    International Journal of Molecular Sciences.2022; 23(13): 6981.     CrossRef
  • Oesophageal and gastric cancers: From epidemiology to modern treatment
    Nikola Milošević, Srđan Milanović
    Glasnik javnog zdravlja.2022; 96(2): 203.     CrossRef
  • Diagnosis of the Primary Tumor Site in the Case of Liver Metastatic Carcinoma
    Mercedes Malone, Christopher Bray, Xiaolong Sean Liu
    Cureus.2022;[Epub]     CrossRef
  • Probe electrospray ionization mass spectrometry‐based rapid diagnosis of liver tumors
    Hiroyuki Hakoda, Sho Kiritani, Takashi Kokudo, Kentaro Yoshimura, Tomohiko Iwano, Meguri Tanimoto, Takeaki Ishizawa, Junichi Arita, Nobuhisa Akamatsu, Junichi Kaneko, Sen Takeda, Kiyoshi Hasegawa
    Journal of Gastroenterology and Hepatology.2022; 37(11): 2182.     CrossRef
  • Case report: Rare isolated cystic hepatic metastasis of a patient with squamous cell lung carcinoma history and the prognosis
    Chunbao Liu, Xiaomin Chen, Hang Su, Liang Xia, Diyu Lu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Liver Metastases: Correlation between Imaging Features and Pathomolecular Environments
    Kumi Ozaki, Shohei Higuchi, Hirohiko Kimura, Toshifumi Gabata
    RadioGraphics.2022; 42(7): 1994.     CrossRef
  • Metastatic ovarian tumor from pancreatic cancer treated with combined immunotherapy: A case report
    Yiying Tao, Lei Tang, Li Zuo, Yue Ma, Fengchun Zhang, Yingchun Xu
    Oncology Letters.2022;[Epub]     CrossRef
  • Prognostic Significance of CDH1, FN1 and VIM for Early Recurrence in Patients with Colorectal Liver Metastasis After Liver Resection
    Aleksandar Bogdanovic, Jovana Despotovic, Danijel Galun, Nemanja Bidzic, Aleksandra Nikolic, Jovana Rosic, Zoran Krivokapic
    Cancer Management and Research.2021; Volume 13: 163.     CrossRef
  • Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics
    Bing Mao, Jingdong Ma, Shaobo Duan, Yuwei Xia, Yaru Tao, Lianzhong Zhang
    European Radiology.2021; 31(7): 4576.     CrossRef
  • Real-time lipid patterns to classify viable and necrotic liver tumors
    Pierre-Maxence Vaysse, Heike I. Grabsch, Mari F.C.M. van den Hout, Marc H.A. Bemelmans, Ron M.A. Heeren, Steven W.M. Olde Damink, Tiffany Porta Siegel
    Laboratory Investigation.2021; 101(3): 381.     CrossRef
  • Self-organization in cancer: Implications for histopathology, cancer cell biology, and metastasis
    Senthil K. Muthuswamy
    Cancer Cell.2021; 39(4): 443.     CrossRef
  • Cervical lymph node enlargement as the initial manifestation of rectal cancer
    Tong-Hui Xie, Peng Su, Jian-Guo Hong, Hui Zhang
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • Management of indeterminate hepatic nodules and evaluation of factors predicting their malignant potential in patients with colorectal cancer
    Mizelle D’Silva, Jai Young Cho, Ho-Seong Han, Taupyk Yerlan, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim
    Scientific Reports.2021;[Epub]     CrossRef
  • Evaluation of the Diagnostic Performance of Positron Emission Tomography/Magnetic Resonance for the Diagnosis of Liver Metastases
    Caiyuan Zhang, Aileen O'Shea, Chiara Anna Parente, Barbara Juarez Amorim, Peter Caravan, Christina R. Ferrone, Lawrence S. Blaszkowsky, Andrea Soricelli, Marco Salvatore, David Groshar, Hanna Bernstine, Liran Domachevsky, Lina Garcia Canamaque, Lale Umutl
    Investigative Radiology.2021; 56(10): 621.     CrossRef
  • Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors
    Anne Menz, Rifka Bauer, Martina Kluth, Clara Marie von Bargen, Natalia Gorbokon, Florian Viehweger, Maximilian Lennartz, Cosima Völkl, Christoph Fraune, Ria Uhlig, Claudia Hube-Magg, Noémi De Wispelaere, Sarah Minner, Guido Sauter, Simon Kind, Ronald Simo
    Human Pathology.2021; 115: 19.     CrossRef
  • Cholangiocarcinoma
    Samantha Sarcognato, Diana Sacchi, Matteo Fassan, Luca Fabris, Massimiliano Cadamuro, Giacomo Zanus, Ivana Cataldo, Paola Capelli, Francesca Baciorri, Matilde Cacciatore, Maria Guido
    Pathologica.2021; 113(3): 158.     CrossRef
  • Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing
    Jun-Kyu Kang, Sunghoon Heo, Hwang-Phill Kim, Sang-Hyun Song, Hongseok Yun, Sae-Won Han, Gyeong Hoon Kang, Duhee Bang, Tae-You Kim, Alvaro Galli
    PLOS ONE.2020; 15(5): e0232754.     CrossRef
  • Metastatic breast cancer presenting as acute liver injury: diagnostic dilemma in the setting of suspected hemochromatosis
    Raguraj Chandradevan, Hironobu Takeda, Benjamin Hayes, Kalli Faulkner, Matthew Darrow
    Oxford Medical Case Reports.2020;[Epub]     CrossRef
  • Critical steps to tumor metastasis: alterations of tumor microenvironment and extracellular matrix in the formation of pre-metastatic and metastatic niche
    Jianan Zhuyan, Mingyu Chen, Tianhao Zhu, Xunxia Bao, Timing Zhen, Kaichen Xing, Qiubo Wang, Sibo Zhu
    Cell & Bioscience.2020;[Epub]     CrossRef
  • Colorectal liver metastases: radiopathological correlation
    Luisa Paulatto, Marco Dioguardi Burgio, Riccardo Sartoris, Aurélie Beaufrère, François Cauchy, Valérie Paradis, Valérie Vilgrain, Maxime Ronot
    Insights into Imaging.2020;[Epub]     CrossRef
  • Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging
    Domenico Alvaro, Cesare Hassan, Vincenzo Cardinale, Guido Carpino, Luca Fabris, Enrico Gringeri, Vincenza Granata, Massimiliano Mutignani, Helen Morement, Felice Giuliante, Alfredo Guglielmi, Lorenzo Ridola, Marco Marzioni, Gianluca Grazi, Maria Guido, Em
    Digestive and Liver Disease.2020; 52(11): 1282.     CrossRef
  • Hepatocellular carcinomas can be Special AT-rich sequence-binding protein 2 positive: an important diagnostic pitfall
    Whayoung Lee, Xiaodong Li, Vishal S. Chandan
    Human Pathology.2020; 105: 47.     CrossRef
  • Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans
    Wei Yu, Sanjit K. Roy, Yiming Ma, Thomas A. LaVeist, Sharmila Shankar, Rakesh K. Srivastava
    Journal of Cellular and Molecular Medicine.2019; 23(12): 7999.     CrossRef
  • 35,252 View
  • 1,181 Download
  • 51 Web of Science
  • Crossref

Liver Pathologys

Hepatic neoplasm

Primary adenosquamous carcinoma of the liver: a case report
Kyung Han Nam, Ji Yeon Kim
Clin Mol Hepatol 2016;22(4):503-508.
Published online December 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0077
Adenosquamous carcinoma of the liver is a rare variant of cholangiocarcinoma. It is known to be a highly aggressive tumor with a poor prognosis, but its pathogenesis remains unclear owing to limited data in the literature. We report a case of 56-year-old woman who presented with a 1-week history of epigastric pain. Magnetic resonance imaging revealed a 6.5-cm ill-defined mass with low signal intensity in the left lobe of the liver, which was suspicious of cholangiocarcinoma. The patient underwent left hemihepatectomy. Microscopically, the tumor consisted of malignant glandular and squamous components and staged as pT2aN1. Despite postoperative chemoradiation, the patient had recurrence 8 months after surgery.

Citations

Citations to this article as recorded by  Crossref logo
  • Hepatic adenosquamous carcinoma with sarcomatous transformation: a case report and review of the literature
    Quynh Thi Nguyen, Hiep Canh Nguyen, Kenta Takahashi, Kaori Yoshimura, Hiroko Ikeda, Kazuto Kozaka, Zihan Li, Dong Thanh Le, Rui Yang, Shintaro Yagi, Kenichi Harada
    Medical Molecular Morphology.2025; 58(1): 75.     CrossRef
  • Use of sintilimab in primary adenosquamous carcinoma of the liver results in pathological complete response: a case report and literature review
    Zhiqing Bai, Yu-Ann Chen, Ying Xiao, Jianping Song, Jianwei Song, Canhong Xiang
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • New insights into the adverse prognostic role of squamous differentiation in intrahepatic cholangiocarcinoma: A comprehensive analysis
    Quynh Nguyen Thi, Hiep Nguyen Canh, Zihan Li, Khuyen Nguyen Thi, Kaori Yoshimura, Kenta Takahashi, Rui Yang, Dong Le Thanh, Tram Nguyen Thi, Shintaro Yagi, Kenichi Harada
    Human Pathology.2025; 160: 105824.     CrossRef
  • Immunotherapy as adjuvant therapy for a patient with adenosquamous carcinoma of the intrahepatic bile duct: A case report and literature review
    Jun Feng, Aimaiti Yasen, Tianxing Dai, Runbin Liang, Zhihong Liao, Ping He, Zhihong Lin, Guoying Wang
    Liver Research.2023; 7(2): 156.     CrossRef
  • Adenosquamous carcinoma of the liver: The challenge of diagnosis
    Ye‐Min Liu, Ya‐Li Lei, Fang Liu
    Liver International.2023; 43(10): 2320.     CrossRef
  • Primary hepatic adenosquamous carcinoma: a case report and review of the literature
    Haidong Ai, Ting Gong, Yongbiao Ma, Guixu Ma, Jingjing Zhao, Xuelin Zhao
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Advanced primary adenosquamous carcinoma of the liver with a small cell carcinoma component: an autopsy case report
    Takuto Nosaka, Masahiro Ohtani, Shouichi Namikawa, Kazuto Takahashi, Tatsushi Naito, Kazuya Ofuji, Hidetaka Matsuda, Katsushi Hiramatsu, Yoshiaki Imamura, Yasunari Nakamoto
    Clinical Journal of Gastroenterology.2021; 14(5): 1496.     CrossRef
  • Treatment and Survival Patterns of Primary Adenosquamous Carcinoma of the Liver: A Retrospective Analysis
    Qiheng Gou, Shengya Fu, Yuxin Xie, Mengni Zhang, Yali Shen
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Primary Adenosquamous Carcinoma of the Liver on FDG PET/CT
    Nuh Filizoglu, Kevser Oksuzoglu, Salih Ozguven
    Clinical Nuclear Medicine.2021; 46(12): e572.     CrossRef
  • Unresectable primary hepatic adenosquamous carcinoma successfully treated with systemic and transcatheter hepatic arterial injection chemotherapies followed by conversion surgery: a case report and literature review
    Yusuke Watanabe, Akihiko Osaki, Kiwamu Kimura, Shunta Yakubo, Kenichi Takaku, Munehiro Sato, Hideki Hashidate, Nobuo Waguri, Shuji Terai
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • A rare case of primary adenosquamous carcinoma of the liver with gallbladder metastasis
    Po‐Hsuan Wu, Yue‐Chiu Su, Kung‐Kai Kuo
    The Kaohsiung Journal of Medical Sciences.2020; 36(7): 561.     CrossRef
  • Transverse colon invasion from intrahepatic cholangiocarcinoma with lymph node metastasis in the regional mesocolon: a case report
    Kenta Aso, Kyoji Ito, Nobuyuki Takemura, Fuyuki Inagaki, Fuminori Mihara, Norihiro Kokudo
    Surgical Case Reports.2020;[Epub]     CrossRef
  • Adenosquamous carcinoma of the digestive system: a literature review
    Hong-Shuai Li, Tao He, Li-Li Yang
    Scandinavian Journal of Gastroenterology.2020; 55(11): 1268.     CrossRef
  • CT and MR imaging features of pancreatic adenosquamous carcinoma and their correlation with prognosis
    Rui Zhao, Zhenyu Jia, Xiao Chen, Shuai Ren, Wenjing Cui, Deng-ling Zhao, Shaojuan Wang, Jianhua Wang, Tao Li, Yong Zhu, Xiaowen Tang, Zhongqiu Wang
    Abdominal Radiology.2019; 44(8): 2822.     CrossRef
  • 11,429 View
  • 128 Download
  • 13 Web of Science
  • Crossref

Hepatic neoplasm

Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report
Hye Min Kim, Haeryoung Kim, Young Nyun Park
Clin Mol Hepatol 2015;21(3):309-313.
Published online September 30, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.3.309

Citations

Citations to this article as recorded by  Crossref logo
  • Hepatic Undifferentiated Carcinoma With Osteoclast Like Giant Cell With Dominant Intraductal Growth: A Case Report With Literature Review
    Yu-Chien Ko, Tse-Ching Chen
    International Journal of Surgical Pathology.2025; 33(8): 1784.     CrossRef
  • Ultrasonographic features and blood biochemistry findings of cholangiocarcinoma in a captive polar bear (Ursus maritimus)
    Keita Kakisaka, Nozomu Yokoyama, Fuka Takahashi, Keisuke Aoshima, Mitsuyoshi Takiguchi
    Veterinary Record Case Reports.2025;[Epub]     CrossRef
  • Contrast-enhanced ultrasound features of hepatic sarcomatoid carcinoma different from hepatocellular carcinoma
    Qiannan Zhao, Zhengbiao Ji, Yanling Chen, Kun Wang, Yijie Qiu, Xiaofan Tian, Yuli Zhu, Hong Qin, Hong Han, Haixia Yuan, Yi Dong, Wenping Wang
    Clinical Hemorheology and Microcirculation.2024; 87(1): 55.     CrossRef
  • A case of rapidly progressing sarcomatous intrahepatic cholangiocarcinoma with suddenly appearing lymph node metastasis
    Eisho Kanemitsu, Rei Takahashi, Setsuko Nakanishi, Satoru Sueyoshi, Atsushi Kobayashi, Takao Nishimura, Hiromitsu Nagata
    Surgical Case Reports.2024;[Epub]     CrossRef
  • Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma
    Joon Hyuk Choi, Swan N. Thung
    Cancers.2024; 16(8): 1537.     CrossRef
  • Rare histotypes of epithelial biliary tract tumors: A literature review
    Elena Sapuppo, Oronzo Brunetti, Dalila Tessitore, Giovanni Brandi, Nicola Di Giovanni, Guido Fadda, Claudio Luchini, Maurizio Martini, Davide Quaresmini, Antonio Russo, Mariacarmela Santarpia, Aldo Scarpa, Mario Scartozzi, Giovanni Tuccari, Tindara Franch
    Critical Reviews in Oncology/Hematology.2023; 181: 103892.     CrossRef
  • Системна хiмiотерапiя при нерезектабельнiй формi внутрiшньопечiнкової саркоматоїдної холангiокарциноми: клiнiчний випадок та огляд лiтератури
    O.V. Hrуnenko, Iu.I. Zaivelieva, V.O. Kropelnytskyi, O.M. Ostapyshen, D.O. Fedorov
    Practical oncology.2023; 6(1): 35.     CrossRef
  • First report on establishment and characterization of the extrahepatic cholangiocarcinoma sarcoma cell line CBC2T-2
    Ning-Zu Jiang, Ming-Zhen Bai, Chong-Fei Huang, Ze-Long Ma, Ru-Yang Zhong, Wen-Kang Fu, Long Gao, Liang Tian, Ning-Ning Mi, Hai-Dong Ma, Ya-Wen Lu, Zi-Ang Zhang, Jin-Yu Zhao, Hai-Ying Yu, Bao-Ping Zhang, Xian-Zhuo Zhang, Yan-Xian Ren, Chao Zhang, Yong Zhan
    World Journal of Gastroenterology.2023; 29(41): 5683.     CrossRef
  • Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis
    Tian-Run Lv, Hai-Jie Hu, Parbatraj Regmi, Fei Liu, Fu-Yu Li
    Journal of Cancer Research and Clinical Oncology.2022; 148(7): 1685.     CrossRef
  • Recurrent hepatocellular carcinoma with osteoclast-like giant cells: a case report
    Mone Tsukimoto, Kazushi Sugimoto, Ryuta Shigefuku, Ryosuke Sugimoto, Hiroto Yuasa, Katsunori Uchida, Norihiko Yamamoto
    Journal of Medical Case Reports.2022;[Epub]     CrossRef
  • Undifferentiated Carcinoma with Osteoclast-Like Giant Cells of the Common Bile Duct: A Case Report of a Rare Entity at an Unusual Location
    Chuan-Han Chen, Hsin-Ni Li
    Diagnostics.2022; 12(7): 1517.     CrossRef
  • Clinical diagnosis and treatment strategies for sarcomatoid intrahepatic cholangiocarcinoma
    Xia Sheng, Jian-Min Qin
    World Chinese Journal of Digestology.2022; 30(14): 614.     CrossRef
  • Intrahepatic sarcomatoid cholangiocarcinoma: A case report of the youngest patient on record and a review of the condition's characteristics
    Long-Fu Xi, Yun Jin, Jiang-Tao Li
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition
    Kemal Behzatoglu
    Pathology and Oncology Research.2021;[Epub]     CrossRef
  • Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis
    Tao Wang, Junjie Kong, Xianwei Yang, Shu Shen, Menglan Zhang, Wentao Wang
    Journal of Surgical Oncology.2020; 121(3): 524.     CrossRef
  • Sarcomatoid intrahepatic cholangiocarcinoma mimicking liver abscess: A case report
    Yan Wang, Jia-Lei Ming, Xing-Yu Ren, Lu Qiu, Li-Juan Zhou, Shu-Dong Yang, Xiang-Ming Fang
    World Journal of Clinical Cases.2020; 8(1): 208.     CrossRef
  • Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma
    Jian-Ping Wang, Zhi-Gang Yao, Ya-Wen Sun, Xi-Han Liu, Feng-Kai Sun, Cun-Hu Lin, Fu-Xin Ren, Bei-Bei Lv, Shuai-Jun Zhang, Yang Wang, Fan-Ying Meng, Shun-Zhen Zheng, Wei Gong, Jun Liu
    World Journal of Gastroenterology.2020; 26(29): 4327.     CrossRef
  • Sarcomatoid intrahepatic cholangiocarcinoma in a patient with poor prognosis: a case report and literature review
    Xu Li, Jian Li, Kai Liu, Ludong Tan, Yahui Liu
    Journal of International Medical Research.2020;[Epub]     CrossRef
  • Analysis of intrahepatic sarcomatoid cholangiocarcinoma: Experience from 11 cases within 17 years
    Dong Kyun Kim, Bo Ra Kim, Jin Sook Jeong, Yang Hyun Baek
    World Journal of Gastroenterology.2019; 25(5): 608.     CrossRef
  • Intrahepatic Sarcomatous Cholangiocarcinoma: Case Report and Review of the Literature
    Thana Boonsinsukh, Vichit Viriyaroj, Thammanij Rookkachart, Therdkiat Trongwongsa
    Case Reports in Surgery.2018; 2018: 1.     CrossRef
  • A Case of Hepatic Angiosarcoma with Osteoclast-like Giant Cells
    Takahiro MIZUI, Keigo MURAKAMI, Yasuyuki HARA, Shigehito MIYAGI, Takeshi NAITOH, Michiaki UNNO, Takashi KAMEI
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2018; 79(2): 382.     CrossRef
  • Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
    Kyohei Yugawa, Tomoharu Yoshizumi, Yohei Mano, Noboru Harada, Shinji Itoh, Toru Ikegami, Yuji Soejima, Nobuhiro Fujita, Kenichi Kohashi, Shinichi Aishima, Yoshinao Oda, Masaki Mori
    Surgical Case Reports.2018;[Epub]     CrossRef
  • Intrahepatic sarcomatoid cholangiocarcinoma
    Sara Sintra, Rui Costa, Carlos Filipe, Adélia Simão
    BMJ Case Reports.2018; 2018: bcr-2018-225017.     CrossRef
  • Validation of difficulty scoring system for laparoscopic liver resection in patients who underwent laparoscopic left lateral sectionectomy
    Chami Im, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Jae Yool Jang, Hanlim Choi, Jae Seong Jang, Seong Uk Kwon
    Surgical Endoscopy.2017; 31(1): 430.     CrossRef
  • 12,684 View
  • 91 Download
  • 21 Web of Science
  • Crossref

Liver fibrosis, cirrhosis, and portal hypertension

Budd-Chiari syndrome with multiple large regenerative nodules
Haeryoung Kim, Ji Hae Nahm, Young Nyun Park
Clin Mol Hepatol 2015;21(1):89-94.
Published online March 25, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.1.89

Citations

Citations to this article as recorded by  Crossref logo
  • Characteristics of Regenerative Nodules and Their Relationship with Hepatocellular Carcinoma in Budd-Chiari Syndrome, and Role of Computed Tomography in Diagnosis and Follow-Up
    Umut Tüysüz, İmam Bakır Batı
    Indian Journal of Surgery.2024; 86(1): 172.     CrossRef
  • Budd‐Chiari syndrome in children: Radiological intervention and role of shear wave elastography in monitoring response
    Arghya Samanta, Anshu Srivastava, Rajnikant Yadav, Aditya Kapoor, Anindya Ghosh, Prabhakar Mishra, Moinak Sen Sarma, Ujjal Poddar
    Journal of Pediatric Gastroenterology and Nutrition.2024; 78(1): 17.     CrossRef
  • Masquerading Spleen: A Perplexing Case of Intrahepatic Splenosis Mimicking Hepatocellular Carcinoma
    Noriko Ikeda, Yujo Kawashita, Masaki Tateishi, Takashi Ueda, Junzo Yamaguchi, Yasuo Washida, Yoichi Hachitanda
    Cureus.2024;[Epub]     CrossRef
  • Focal Liver Lesions in Budd-Chiari Syndrome: Spectrum of Imaging Findings
    Francesco Rizzetto, Davide Rutanni, Luca Alessandro Carbonaro, Angelo Vanzulli
    Diagnostics.2023; 13(14): 2346.     CrossRef
  • Diagnostic challenges and risk stratification of hepatocellular adenoma
    Dana Balitzer, Sanjay Kakar
    Diagnostic Histopathology.2022; 28(2): 89.     CrossRef
  • Cardiovascular Disease in Primary Sjögren’s Syndrome: Raising Clinicians’ Awareness
    Mihnea Casian, Ciprian Jurcut, Alina Dima, Ancuta Mihai, Silviu Stanciu, Ruxandra Jurcut
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Parenchymal Extinction Mimicking Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B-Related Liver Cirrhosis
    Min Kyu Kang, Joon Hyuk Choi
    Diagnostics.2021; 11(7): 1171.     CrossRef
  • Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)
    Akash Shukla, Ananta Shreshtha, Amar Mukund, Chhagan Bihari, C. E. Eapen, Guohong Han, Hemant Deshmukh, Ian Homer Y. Cua, Cosmas Rinaldi Adithya Lesmana, Mamun Al Meshtab, Masayoshi Kage, Roongruedee Chaiteeraki, Sombat Treeprasertsuk, Suprabhat Giri, Sun
    Hepatology International.2021; 15(3): 531.     CrossRef
  • Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis
    Virginia Hernández-Gea, Andrea De Gottardi, Frank W.G. Leebeek, Pierre-Emmanuel Rautou, Riad Salem, Juan Carlos Garcia-Pagan
    Journal of Hepatology.2019; 71(1): 175.     CrossRef
  • Benign and malignant hepatocellular lesions in patients with vascular liver diseases
    Valérie Vilgrain, Valérie Paradis, Morgane Van Wettere, Dominique Valla, Maxime Ronot, Pierre-Emmanuel Rautou
    Abdominal Radiology.2018; 43(8): 1968.     CrossRef
  • Hepatocellular nodules in vascular liver diseases
    Christine Sempoux, Charles Balabaud, Valérie Paradis, Paulette Bioulac-Sage
    Virchows Archiv.2018; 473(1): 33.     CrossRef
  • Budd-Chiari Syndrome: What Pathologists Need to Know About Hepatic Venous Outflow Obstruction
    Meredith E. Pittman
    AJSP: Reviews and Reports.2018; 23(5): 228.     CrossRef
  • Ruptured hepatocellular carcinoma in a child with Budd-Chiari syndrome
    Anandini Suri, Varun K. Sharma, Prajakta R. Ranade, Shaji Marar, Aabha Nagral
    Indian Pediatrics.2016; 53(9): 833.     CrossRef
  • 11,243 View
  • 113 Download
  • 11 Web of Science
  • Crossref

Hepatic neoplasm

Intrahepatic cholangiocarcinoma arising in Caroli's disease
Min Hye Jang, Yoon Jin Lee, Haeryoung Kim
Clin Mol Hepatol 2014;20(4):402-405.
Published online December 24, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.4.402

Citations

Citations to this article as recorded by  Crossref logo
  • PIWI-interacting RNAs (PiRNAs) as emerging biomarkers and therapeutic targets in biliary tract cancers: A comprehensive review
    Sahar Ahmadi Asouri, Esmat Aghadavood, Hamed Mirzaei, Alireza Abaspour, Mohammad Esmaeil Shahaboddin
    Heliyon.2024; 10(13): e33767.     CrossRef
  • The Constellation of Risk Factors and Paraneoplastic Syndromes in Cholangiocarcinoma: Integrating the Endocrine Panel Amid Tumour-Related Biology (A Narrative Review)
    Mihai-Lucian Ciobica, Bianca-Andreea Sandulescu, Liana-Maria Chicea, Mihaela Iordache, Maria-Laura Groseanu, Mara Carsote, Claudiu Nistor, Ana-Maria Radu
    Biology.2024; 13(9): 662.     CrossRef
  • The multidisciplinary management of cholangiocarcinoma
    Kim C. Ohaegbulam, Yilun Koethe, Alice Fung, Skye C. Mayo, Aaron J. Grossberg, Emerson Y. Chen, Kaveh Sharzehi, Adel Kardosh, Khashayar Farsad, Flavio G. Rocha, Charles R. Thomas, Nima Nabavizadeh
    Cancer.2023; 129(2): 184.     CrossRef
  • Research Progress on Risk Factors of Cholangiocarcinoma
    彬彬 彭
    Advances in Clinical Medicine.2023; 13(03): 4025.     CrossRef
  • Biliary Duct Hamartomas: A Systematic Review
    Abdul Ahad E Sheikh, Anthony P Nguyen, Katarina Leyba, Nismat Javed, Sana Shah, Alexander Deradke, Christopher Cormier, Rahul Shekhar, Abu Baker Sheikh
    Cureus.2022;[Epub]     CrossRef
  • Portal hypertension: An uncommon presentation of Caroli's syndrome
    Akash Raut, Suraj Shrestha, Sushan Homagain, Amar Jayswal, Bikal Ghimire
    Clinical Case Reports.2020; 8(12): 3133.     CrossRef
  • Diffuse oligosymptomatic caroli's disease: case report
    Yassine Lemfadli
    MOJ Clinical & Medical Case Reports.2020; 10(4): 81.     CrossRef
  • Diffuse oligosymptomatic Caroli’s disease: Case report
    Lemfadli Y, Bouchrit S, Fatimezzhara Lairani, Ait Errami A, Oubaha S, Samlani Z, Krati K
    Global Journal of Medical and Clinical Case Reports.2020; 7(2): 064.     CrossRef
  • Caroli syndrome: a clinical case with detailed histopathological analysis
    Mikhail Mavlikeev, Angelina Titova, Renata Saitburkhanova, Maria Abyzova, Ilyas Sayfutdinov, Nasima Gizzatullina, Ilya Kotov, Igor Plaksa, Artur Isaev, Sayar Abdulkhakov, Andrey Kiyasov, Roman Deev
    Clinical Journal of Gastroenterology.2019; 12(2): 106.     CrossRef
  • Cholangiocarcinoma: Epidemiology and risk factors
    Shahid A. Khan, Simona Tavolari, Giovanni Brandi
    Liver International.2019; 39(S1): 19.     CrossRef
  • Remodeling of Intrahepatic Ducts in a Model of Caroli Syndrome: Is Scar Carcinoma a Consequence of Laplace’s Law?
    Bharvi M. Chavre, Kai Jiang, Luce G. St. Surin, Terrence Bissoondial, Ping Zhou, Jingsong Li, Satishkumar V. Gadhiya, Itzhak D. Goldberg, Prakash Narayan
    Medical Sciences.2019; 7(4): 55.     CrossRef
  • Laparoscopic hepatectomy for the treatment of Caroli's disease: a case report
    Chao-bo Chen, Wei-dong Hu, Wan-wen Zhao, Yan-yan Gu, Hong-wei Hou, Zheng Pan
    Annals of Surgical Treatment and Research.2018; 94(3): 162.     CrossRef
  • Prenatal Diagnosis of Caroli Disease Associated With Autosomal Recessive Polycystic Kidney Disease by 3-D Ultrasound and Magnetic Resonance Imaging
    Pedro Teixeira Castro, Ana Paula Pinho Matos, Heron Werner, Pedro Daltro, Tatiana Fazecas, Renata Nogueira, Edward Araujo Júnior
    Journal of Obstetrics and Gynaecology Canada.2017; 39(12): 1176.     CrossRef
  • 9,817 View
  • 98 Download
  • 16 Web of Science
  • Crossref

Hepatic neoplasm

Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern
Ji-Young Choe, Haeryoung Kim
Clin Mol Hepatol 2014;20(2):214-217.
Published online June 30, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.2.214

Citations

Citations to this article as recorded by  Crossref logo
  • Prognostic implications of tumor histology and microenvironment in surgically resected intrahepatic cholangiocarcinoma: a single institutional experience
    Irene Y. Chen, Richard F. Dunne, Xiaoyan Liao
    Virchows Archiv.2025; 486(2): 323.     CrossRef
  • Synchronous Hepatocellular and Intrahepatic Cholangiocellular Carcinoma With Predominant Ductal Plate Malformation Pattern. A Case Report and Review of the Literature
    Rita Szodorai, Emőke Fülöp, Andrei Fülöp, Radu Mircea Neagoe, Simona Gurzu
    Cancer Reports.2025;[Epub]     CrossRef
  • Cholangiolocarcinoma with Ductal Plate Malformation Pattern: A 6-Year Follow-Up
    Yuta Ushida, Gen Sugawara, Takayuki Minami, Yoriko Yamashita, Masaya Inoue
    Surgical Case Reports.2025; 11(1): n/a.     CrossRef
  • Characterization of Cholangiocarcinomas With Tubulocystic Morphology Associated With Biliary Adenofibroma or Biliary Adenofibroma-Like Lesions
    Xiaoyan Liao, Diana Agostini-Vulaj, Rena X. Li, Xuchen Zhang
    Modern Pathology.2025; 38(10): 100815.     CrossRef
  • Immunohistochemistry in intrahepatic cholangiocarcinoma: histological subtyping and drug selection
    Han Wang, Miao-Xia He, Wen-Ming Cong, Hui Dong
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Neoplastic ductal plate malformation pattern rather than von Meyenburg complexes may be an early neoplastic lesion of small duct-type intrahepatic cholangiocarcinoma
    Yasuni Nakanuma, Motoko Sasaki, Yuko Kakuda, Kenichi Harada, Yasunori Sato, Takashi Sugino
    Human Pathology.2025; 161: 105865.     CrossRef
  • Mixed Plate Ductal Intrahepatic Cholangiocarcinoma Mimicking Hepatocellular Carcinoma
    Sania Ajmal, Srujan Edupuganti, Adiraj Singh
    Cureus.2024;[Epub]     CrossRef
  • The morphomolecular features of cholangiocarcinoma in the personalised era
    Daniel T. Field, Guido Carpino, Michail Doukas, Timothy J. Kendall
    Diagnostic Histopathology.2024; 30(4): 237.     CrossRef
  • Histopathological evidence of intrahepatic cholangiocarcinoma occurring in ductal plate malformation: A clinicopathologic study of 5 cases
    Qian Wang, Yi Xu, Shou-Mei Wang, Ai-Yan Hu, Yun-Cui Pan, Shu-Hui Zhang
    Annals of Diagnostic Pathology.2021; 55: 151828.     CrossRef
  • Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
    Chaobo Chen, Hanghang Wu, Hui Ye, Agustín Tortajada, Sandra Rodríguez-Perales, Raúl Torres-Ruiz, August Vidal, Maria Isabel Peligros, Johanna Reissing, Tony Bruns, Mohamed Ramadan Mohamed, Kang Zheng, Amaia Lujambio, Maria J. Iraburu, Leticia Colyn, Maria
    Cancers.2021; 14(1): 78.     CrossRef
  • Congenital hepatic fibrosis and its mimics: a clinicopathologic study of 19 cases at a single institution
    Irene Y. Chen, Christa L. Whitney-Miller, Xiaoyan Liao
    Diagnostic Pathology.2021;[Epub]     CrossRef
  • Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns
    Carlie S. Sigel, Esther Drill, Yi Zhou, Olca Basturk, Gokce Askan, Linda M. Pak, Efsevia Vakiani, Tao Wang, Thomas Boerner, Richard K.G. Do, Amber L. Simpson, William Jarnagin, David S. Klimstra
    American Journal of Surgical Pathology.2018; 42(10): 1334.     CrossRef
  • Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma
    Kyoung-Bun Lee
    Clinical and Molecular Hepatology.2016; 22(3): 400.     CrossRef
  • Cholangiolocellular Carcinoma Arising in a Normal Liver
    Chie Kitami, Yasuyuki Kawachi, Toshihiko Igarashi, Shigeto Makino, Atsushi Nishimura, Mikako Kawahara, Keiya Niikuni, Kenichi Harada
    The Japanese Journal of Gastroenterological Surgery.2016; 49(10): 1006.     CrossRef
  • 10,165 View
  • 91 Download
  • 14 Web of Science
  • Crossref

Vascular disorders of liver

Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy
An Na Seo, Haeryoung Kim
Clin Mol Hepatol 2014;20(1):81-84.
Published online March 26, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.1.81

Citations

Citations to this article as recorded by  Crossref logo
  • Imaging of hepato-pancreato-biliary emergencies in patients with cancer
    Ankush Jajodia, Philippe Soyer, Maxime Barat, Michael N. Patlas
    Diagnostic and Interventional Imaging.2024; 105(2): 47.     CrossRef
  • Blue Liver
    Kiyoshi Takemoto, Saiho Ko, Kazuaki Atagi
    The American Journal of the Medical Sciences.2024; 368(4): e43.     CrossRef
  • Pancreaticoduodenectomy with combined hepatic artery and portal vein resection after laparoscopic division of pancreaticosplenic ligament due to FOLFIRINOX-induced hepatic toxicity related secondary hypersplenism
    Ji Su Kim, Jeong Youp Park, Munseok Choi, Dong Jin Joo, Ho Kyoung Hwang, Woo Jung Lee, Chang Moo Kang
    Annals of Hepato-Biliary-Pancreatic Surgery.2021; 25(2): 307.     CrossRef
  • Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
    Taurean Brown, DeLawrence Sykes, Antiño R. Allen
    Biomedicines.2021; 9(2): 189.     CrossRef
  • Association of albumin–bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib
    Daichi Watanabe, Hironori Fujii, Yunami Yamada, Nobuhisa Matsuhashi, Akitaka Makiyama, Hirotoshi Iihara, Takao Takahashi, Shigeru Kiyama, Ryo Kobayashi, Kazuhiro Yoshida, Akio Suzuki
    International Journal of Clinical Oncology.2021; 26(7): 1257.     CrossRef
  • Hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea
    Jae-Ho Yoon, Chul Won Choi, Jong-Ho Won
    The Korean Journal of Internal Medicine.2021; 36(6): 1261.     CrossRef
  • Imaging of Colorectal Liver Metastases: New Developments and Pending Issues
    Matteo Renzulli, Alfredo Clemente, Anna Maria Ierardi, Irene Pettinari, Francesco Tovoli, Stefano Brocchi, Giuliano Peta, Salvatore Cappabianca, Gianpaolo Carrafiello, Rita Golfieri
    Cancers.2020; 12(1): 151.     CrossRef
  • Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy
    Shinichiro Kobayashi, Sadayuki Okudaira, Kazuma Kobayashi, Kengo Kanetaka, Susumu Eguchi
    Clinical Case Reports.2019; 7(2): 394.     CrossRef
  • The Protective Effect of Naringenin on Oxaliplatin-Induced Genotoxicity in Mice
    Majid A. Ganaie, Basit L. Jan, Tajdar H. Khan, Khalid M. Alharthy, Ishfaq A. Sheikh
    Chemical and Pharmaceutical Bulletin.2019; 67(5): 433.     CrossRef
  • Vitamin E protects human lymphocytes from genotoxicity induced by oxaliplatin
    Mohammad A.Y. Alqudah, Fahmi Y. Al-Ashwal, Karem H. Alzoubi, Mohammad Alkhatatbeh, Omar Khabour
    Drug and Chemical Toxicology.2018; 41(3): 281.     CrossRef
  • Imaging features of hepatic arterial and venous flow abnormalities
    Abigail Mills, Vincent Mellnick
    Clinical Liver Disease.2018; 11(1): 27.     CrossRef
  • Liquiritigenin and liquiritin alleviated MCT-induced HSOS by activating Nrf2 antioxidative defense system
    Zhenlin Huang, Yuchen Sheng, Minwei Chen, Zhanxia Hao, Feifei Hu, Lili Ji
    Toxicology and Applied Pharmacology.2018; 355: 18.     CrossRef
  • Commitment of Scaffold Proteins in the Onco-Biology of Human Colorectal Cancer and Liver Metastases after Oxaliplatin-Based Chemotherapy
    Deborah Rotoli, Manuel Morales, Julio Ávila, María Maeso, María García, Ali Mobasheri, Pablo Martín-Vasallo
    International Journal of Molecular Sciences.2017; 18(4): 891.     CrossRef
  • Oral siRNA Delivery to Treat Colorectal Liver Metastases
    Sung Hun Kang, Vishnu Revuri, Sang-Joon Lee, Sungpil Cho, In-Kyu Park, Kwang Jae Cho, Woo Kyun Bae, Yong-kyu Lee
    ACS Nano.2017; 11(10): 10417.     CrossRef
  • Target hepatic artery regional chemotherapy and bevacizumab perfusion in liver metastatic colorectal cancer after failure of first-line or second-line systemic chemotherapy
    Hui Chen, Ji Zhang, Guang Cao, Peng Liu, Haifeng Xu, Xiaodong Wang, Xu Zhu, Song Gao, Jianhai Guo, Linzhong Zhu, Pengjun Zhang
    Anti-Cancer Drugs.2016; 27(2): 118.     CrossRef
  • Chlorogenic acid suppresses monocrotaline-induced sinusoidal obstruction syndrome: The potential contribution of NFκB, Egr1, Nrf2, MAPKs and PI3K signals
    Zhiyong Zheng, Liang Shi, Yuchen Sheng, Jiaqi Zhang, Bin Lu, Lili Ji
    Environmental Toxicology and Pharmacology.2016; 46: 80.     CrossRef
  • Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective
    Danny Ngo, Jemianne Bautista Jia, Christopher S. Green, Anjalie T. Gulati, Chandana Lall
    Insights into Imaging.2015; 6(6): 665.     CrossRef
  • Management intra- und postoperativer Blutungen in der Leberchirurgie
    R. Sucher, D. Seehofer, J. Pratschke
    Der Chirurg.2015; 86(2): 114.     CrossRef
  • Imaging of Fluid in Cancer Patients Treated With Systemic Therapy: Chemotherapy, Molecular Targeted Therapy, and Hematopoietic Stem Cell Transplantation
    Abhishek R. Keraliya, Michael H. Rosenthal, Katherine M. Krajewski, Jyothi P. Jagannathan, Atul B. Shinagare, Sree Harsha Tirumani, Nikhil H. Ramaiya
    American Journal of Roentgenology.2015; 205(4): 709.     CrossRef
  • Capecitabine/oxaliplatin

    Reactions Weekly.2015; 1548(1): 61.     CrossRef
  • Chemotherapy induced liver abnormalities: an imaging perspective
    Ankush Sharma, Roozbeh Houshyar, Priya Bhosale, Joon-Il Choi, Rajesh Gulati, Chandana Lall
    Clinical and Molecular Hepatology.2014; 20(3): 317.     CrossRef
  • 11,707 View
  • 109 Download
  • 22 Web of Science
  • Crossref

Benign liver tumors and cystic disease of liver

A sclerosing hemangioma of the liver
Ji Soo Song, Yo Na Kim, Woo Sung Moon
Clin Mol Hepatol 2013;19(4):426-430.
Published online December 28, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.4.426

Citations

Citations to this article as recorded by  Crossref logo
  • Diagnostic Pitfalls of Hepatic Sclerosed Hemangiomas: A Case Report
    Hiroshi Takihara, Shoji Oura, Hiroshi Shintani, Hiroto Tanaka
    Cureus.2025;[Epub]     CrossRef
  • Multiple hepatic sclerosing hemangiomas mimicking malignant lesions, a diagnostic dilemma: case report and literature review
    Dana M. Al Baali, Mahmoud M. Ajoub, Issa S. Al Qarshoubi, Babikir M. Ismail, Abdullah A. Al Rawahi, Fabrizio Panaro, Abdulateef S. Al Sulaimani, Abdullah Y. Al Farai
    Diagnosis.2025;[Epub]     CrossRef
  • Hepatic cavernous hemangioma with degenerative changes with long-term follow-up: a case study
    Kae Hirowatari, Tasuku Nakabori, Sena Higashi, Tomomi Yasue, Mayu Uchida, Akiho Nishiura, Noritoshi Matsuno, Kouzou Misu, Sayako Miyazaki, Kaori Mukai, Kazuyoshi Ohkawa
    Kanzo.2024; 65(4): 179.     CrossRef
  • Giant cavernous hemangioma of the liver with satellite nodules: Aspects on tumour/tissue interface: A case report
    Anne Kristin Fischer, Karl Tobias Erich Beckurts, Reinhard Büttner, Uta Drebber
    World Journal of Hepatology.2023; 15(5): 707.     CrossRef
  • Multiple sclerosing hemangiomas mimicking hepatocellular carcinoma: A case report
    Xinyu Zhan, Yiyun Gao, Jian Xu, Dongming Wu, Ping Wang, Haoming Zhou
    International Journal of Immunopathology and Pharmacology.2023;[Epub]     CrossRef
  • Imaging mimickers of cholangiocarcinoma: a pictorial review
    Si Min Chiow, Hau Wei Khoo, Jee Keem Low, Cher Heng Tan, Hsien Min Low
    Abdominal Radiology.2022; 47(3): 981.     CrossRef
  • Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI
    Jelena Djokic Kovač, Aleksandra Janković, Aleksandra Đikić-Rom, Nikica Grubor, Andrija Antić, Vladimir Dugalić
    Current Oncology.2022; 29(2): 698.     CrossRef
  • Hyalinised hepatic haemangioma mimicking malignancy: an incidental finding
    Rinkey Chaudhary, Tapendra Tiwari, Rajaram Sharma, Saurabh Goyal
    BMJ Case Reports.2022; 15(3): e248176.     CrossRef
  • Added Value of Ultrasound-Based Multimodal Imaging to Diagnose Hepatic Sclerosed Hemangioma before Biopsy and Resection
    Feiqian Wang, Kazushi Numata, Hiromi Nihonmatsu, Makoto Chuma, Naomi Ideno, Akito Nozaki, Katsuaki Ogushi, Mikiko Tanab, Masahiro Okada, Wen Luo, Masayuki Nakano, Masako Otani, Yoshiaki Inayama, Shin Maeda
    Diagnostics.2022; 12(11): 2818.     CrossRef
  • Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study
    Cuiyu Jia, Guangxue Liu, Xinxin Wang, Dawei Zhao, Ruili Li, Hongjun Li
    Japanese Journal of Radiology.2021; 39(11): 1059.     CrossRef
  • Differentiation of Hepatic Sclerosed Hemangiomas From Cavernous Hemangiomas Based on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging Features
    Jeong Ah Hwang, Tae Wook Kang, Dong Ik Cha, Seong Hyun Kim, Sang Yun Ha, Seon Woo Kim
    Journal of Computer Assisted Tomography.2019; 43(5): 762.     CrossRef
  • Hepatic sclerosing hemangioma mimics hepatic malignancies: a case report and multidisciplinary approach
    Dina M. Sweed, Zeinab A. Fayed, Enas M. Sweed, Ahmed El-Sherif, Mohamed Mohamady
    Egyptian Liver Journal.2019;[Epub]     CrossRef
  • Preoperative diagnosis of the sclerosed hemangioma of the liver using multimodality imaging findings: A case report
    Kumi Ozaki, Jun Yoshikawa, Toru Yamamoto, Kazuya Maeda, Yasuharu Kaizaki
    Radiology Case Reports.2018; 13(5): 1025.     CrossRef
  • Hepatic Sclerosing Hemangioma with Predominance of the Sclerosed Area Mimicking a Biliary Cystadenocarcinoma
    Hiroyuki Sugo, Yuki Sekine, Shozo Miyano, Ikuo Watanobe, Michio Machida, Kuniaki Kojima, Hironao Okubo, Ayako Ura, Kanako Ogura, Toshiharu Matsumoto
    Case Reports in Hepatology.2018; 2018: 1.     CrossRef
  • Clinical case report: Sclerosing hemangioma of the liver, a rare but great mimicker
    Siavash Behbahani, Jason C. Hoffmann, Renee Stonebridge, Sabrina Mahboob
    Radiology Case Reports.2016; 11(2): 58.     CrossRef
  • Hepatic Sclerosed Hemangioma: a case report and review of the literature
    Shunsuke Miyamoto, Akihiko Oshita, Yutaka Daimaru, Masaru Sasaki, Hideki Ohdan, Atsushi Nakamitsu
    BMC Surgery.2015;[Epub]     CrossRef
  • Multiple hepatic sclerosing hemangioma mimicking metastatic liver tumor successfully treated by laparoscopic surgery: Report of a case
    Masaki Wakasugi, Shigeyuki Ueshima, Mitsuyoshi Tei, Masayuki Tori, Ken-ichi Yoshida, Masahiko Tsujimoto, Hiroki Akamatsu
    International Journal of Surgery Case Reports.2015; 8: 137.     CrossRef
  • 15,062 View
  • 110 Download
  • Crossref
Well differentiated hepatocellular carcinoma: Pathological diagnosis of needle biopsied Liver tissue
Jae Yeon Seok , Young Nyun Park
Korean J Hepatol 2009;15(1):96-100.
Published online March 31, 2009
DOI: https://doi.org/10.3350/kjhep.2009.15.1.96
  • 4,832 View
  • 29 Download
Angiomyolipoma
Young Nyun Park,Chan Il Park
Korean J Hepatol 2001;7(4):494-496.
52세 여자환자가 간의 종괴를 주소로 입원하여 간엽절제술을 시행받았다. 환자는 1년 전 소화 불량을 주소로 병원을 내원하여 검사 중 간의 종괴가 발견되었으나, 치료를 받지않고 지내왔다. 혈청검사상 AST/ALT 47/ 77 IU/ L, alkaline phosphatase 74 IU/ L, total bilirubin 1.1 mg/ dL, α- fetoprotein < 2 IU/mL, HBsAg (- ), anti-HBs (- ), anti-HCV(- )였다.
  • 3,151 View
  • 16 Download
Hepatocellular Carcinoma Arising in Hepatocellular Adenoma
Mi Sun Choe,Eun Sil Yu
Korean J Hepatol 2002;8(1):107-109.
66세 남자환자가 복부 초음파 검사에서 우연히 발견된 간종괴를 주소로 내원하였다. 과거력 상 특이소견 없었으며 스테로이드 제재 복용력도 없었다. 간 기능 검사는 정상이었으며 HBsAg과 anti-HCVAb는 음성이었고 anti-HBcAb는 양성이었다. α- fetoprotein은 5.1 ng/ml이었다. 환자는 간세포암종이 의심되어 간분절절제술을 받았다.
  • 3,965 View
  • 29 Download

Original Article

Clinical Features of Surgically Resected Focal Nodular Hyperplasia of the Liver
Nam Cheol Hwang, M.D., Moon Seok Choi, M.D., Joon Hyoek Lee, M.D., Kwang Cheol Koh, M.D., Seung Woon Paik, M.D., Byung Chul Yoo, M.D., Jong Chul Rhee, M.D., Kwang-Woong Lee, M.D.*, Jae-Won Joh, M.D.* and Cheol Keun Park, M.D.
Korean J Hepatol 2004;10(2):135-141.
Background/Aims
Focal nodular hyperplasia (FNH) is a benign hepatic tumor with few serious complications and no malignant transformation. However, differential diagnosis between FNH and other liver tumors, especially hepatocellular carcinoma, is often difficult. Methods: Clinical features of surgically resected FNH were reviewed. From January, 1995 to February, 2003, 10 patients with surgically resected FNH were enrolled. Their age, sex, results of laboratory examination, imaging studies and pathologic findings were evaluated. Results: Median age was 37.5 years and sex ratio (male:female) was 1.5:1. In 5 cases, resection to exclude hepatic adenoma or HCC was performed. Four cases were diagnosed incidentally after surgery. Four patients had risk factors for HCC, such as hepatitis B virus infection, liver cirrhosis or both. The size of FNH was 3.2 2.2 cm. The most common site of the tumor was segment 6 (30.0%). Differential diagnosis with HCC was difficult in 5 of six cases in whom CT was performed. Although needle biopsies were performed preoperatively in 4 cases, it was difficult to distinguish FNH from hepatic adenoma or HCC. Conclusions: FNH was resected due to uncertainty of diagnosis, or incidentally during hepatectomy in patients with other liver disease. In the former, differential diagnosis with hepatic adenoma or HCC was a major problem despite extensive work-up including dynamic CT or biopsy. (Korean J Hepatol 2004;10:135-141)
  • 3,510 View
  • 15 Download
Liver Pathology
Extrahepatic Biliary Atresia
So Young Jin
Korean J Hepatol 2004;10(3):233-236.
  • 3,151 View
  • 15 Download